Product Description
Overall, the global diagnostic and interventional catheter market was valued at $266 million in 2023. This is expected to increase over the forecast period at a CAGR of 4.5% to reach $362 million.
Throughout this medical market research, we analyzed over 16 diagnostic & interventional catheter companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite on the global market for diagnostic & interventional catheters extends its projections up to the year 2030, thereby providing a comprehensive and anticipatory understanding of the market trends and trajectories for the given period.
DATA TYPES INCLUDED
- Procedure Numbers, Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Diagnostic & Interventional Catheter Market Insights
Global Diagnostic & Interventional Catheter Market Share Insights
In 2023, Terumo established dominance in the hydrophilic diagnostic catheter market, notably with the versatile Glidecath® catheter featuring 15 tip shapes. Their NaviCross® support catheter gained traction in the U.S. due to its exceptional features and an expanded 0.018” version approved by the FDA in May 2018.
Cook Medical’s strategic pricing approach accelerated the adoption of its support catheter portfolio, particularly the TriForce Peripheral Crossing Set, which gained popularity at a higher price point compared to other support catheters. Cook’s Beacon® Tip catheters returned to the market after a previous recall.
Cardinal Health’s acquisition of Cordis positioned it as a key player in the diagnostic and interventional catheter market, maintaining its leadership in the support catheter segment. The Vista Brite Tip® catheter, known for durability and stability in complex procedures, exemplifies Cardinal Health’s offerings. The company’s stronghold in the peripheral stent market, PTA balloon catheters, and diagnostic products adds to its overall dominance, supported by an aggressive pricing strategy without compromising profits.
Market Segmentation Summary
- Diagnostic Catheters
- Support Catheters
Global Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2023 |
| Forecast | 2024-2030 |
| Historical Data | 2020-2023 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
